{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:09:49Z","timestamp":1787008189837,"version":"build-2736575974"},"reference-count":24,"publisher":"SAGE Publications","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.liebertpub.com\/nv\/resources-tools\/text-and-data-mining-policy\/121\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AIDS Research and Human Retroviruses"],"published-print":{"date-parts":[[2022,10,1]]},"DOI":"10.1089\/aid.2021.0140","type":"journal-article","created":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T05:57:40Z","timestamp":1660283860000},"page":"774-778","source":"Crossref","is-referenced-by-count":13,"title":["Tenofovir, Lamivudine, and Dolutegravir Among Rural Adolescents in Zimbabwe: A Cautionary Tale"],"prefix":"10.1177","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3531-7780","authenticated-orcid":false,"given":"Vinie","family":"Kouamou","sequence":"first","affiliation":[{"name":"Unit of Internal Medicine, University of Zimbabwe, Harare, Zimbabwe."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhoderick","family":"Machekano","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Stellenbosch, Cape Town, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tichaona","family":"Mapangisana","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Stellenbosch, Cape Town, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Maposhere","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Biomedical Research and Training Institute, Harare, Zimbabwe."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shungu","family":"Munyati","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Biomedical Research and Training Institute, Harare, Zimbabwe."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junior","family":"Mutsvangwa","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Biomedical Research and Training Institute, Harare, Zimbabwe."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8931-4484","authenticated-orcid":false,"given":"Tinei","family":"Shamu","sequence":"additional","affiliation":[{"name":"Newlands Clinic, Harare, Zimbabwe."},{"name":"Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland."},{"name":"Graduate School of Health Sciences, University of Bern, Bern, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"McCarty","sequence":"additional","affiliation":[{"name":"Chidamoyo Christian Hospital, Karoi, Zimbabwe."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Katzenstein","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Biomedical Research and Training Institute, Harare, Zimbabwe."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justen","family":"Manasa","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Investigative Sciences, University of Zimbabwe, Harare, Zimbabwe."},{"name":"African Institute for Biomedical Sciences and Technology, Harare, Zimbabwe."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"B1","unstructured":"1. World Health Organization. Guidelines on the Public Health Response to Pre-treatment HIV Drug Resistance. Switzerland; 2017."},{"key":"B2","unstructured":"2. World Health Organization. Updated Recommendations on First-Line and Second-Line Antiretroviral Regimens and Post-Exposure Prophylaxis and Recommendations on Early Infant Diagnosis of HIV: Interim Guidelines: Supplement to the 2016 Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection. Switzerland; 2018."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30036-2"},{"key":"B4","unstructured":"4. Underwood M, DeAnda F, Dorey D, et al. Resistance Post Week 48 in ART-Experienced, Integrase Inhibitor-Naive Subjects with Dolutegravir (DTG) vs. Raltegravir (RAL) in SAILING (ING111762). 13th European Meeting on HIV & Hepatitis Treatment Strategies & Antiviral Drug Resistance. Barcelona, Spain; 2015."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(18)30317-5"},{"key":"B6","unstructured":"6. World Health Organization. Transition to New Antiretroviral Drugs in HIV Programmes: Clinical and Programmatic Considerations. Switzerland; 2017."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232419"},{"key":"B8","unstructured":"8. The National Medicines and Therapeutics Policy Advisory Committee (NMTPAC) and AIDS and TB Directorate of the Ministry of Health and Child Care. Final Addendum to the 2016 ART Guidelines. Zimbabwe; 2019."},{"key":"B9","unstructured":"9. HIV\/TB Care and Treatment Partnership Forum. Final 4 _Rapid COVID 19 Impact Assessment on HIV Service Delivery_CareTreatment. Zimbabwe; 2021."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0245085"},{"key":"B11","unstructured":"11. Ministry of Health and Child Care. Operational and Service Delivery Manual for the Prevention, Care and Treatment of HIV in Zimbabwe. Zimbabwe; 2017."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61221-0"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2017.02.001"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.20.1.21930"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy005"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2009.0081"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002284"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz256"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002470"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3182794723"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32462-0"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky467"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2311-2"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1243"}],"container-title":["AIDS Research and Human Retroviruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.liebertpub.com\/doi\/full-xml\/10.1089\/aid.2021.0140","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.liebertpub.com\/doi\/pdf\/10.1089\/aid.2021.0140","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:16:12Z","timestamp":1777367772000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/aid.2021.0140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,1]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10,1]]}},"alternative-id":["10.1089\/aid.2021.0140"],"URL":"https:\/\/doi.org\/10.1089\/aid.2021.0140","relation":{},"ISSN":["0889-2229","1931-8405"],"issn-type":[{"value":"0889-2229","type":"print"},{"value":"1931-8405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,1]]}}}